1. Home
  2. PK vs CLDX Comparison

PK vs CLDX Comparison

Compare PK & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park Hotels & Resorts Inc.

PK

Park Hotels & Resorts Inc.

HOLD

Current Price

$11.59

Market Cap

2.3B

Sector

Real Estate

ML Signal

HOLD

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

HOLD

Current Price

$26.86

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PK
CLDX
Founded
1946
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.9B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
PK
CLDX
Price
$11.59
$26.86
Analyst Decision
Hold
Buy
Analyst Count
11
10
Target Price
$11.55
$44.10
AVG Volume (30 Days)
3.7M
702.6K
Earning Date
02-19-2026
02-26-2026
Dividend Yield
8.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,541,000,000.00
$2,599,000.00
Revenue This Year
$0.11
N/A
Revenue Next Year
$0.73
$23.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.27
$14.40
52 Week High
$13.90
$30.50

Technical Indicators

Market Signals
Indicator
PK
CLDX
Relative Strength Index (RSI) 60.41 51.43
Support Level $11.13 $25.00
Resistance Level $11.56 $26.99
Average True Range (ATR) 0.38 1.19
MACD 0.05 -0.04
Stochastic Oscillator 79.73 50.46

Price Performance

Historical Comparison
PK
CLDX

About PK Park Hotels & Resorts Inc.

Park Hotels & Resorts owns upper-upscale and luxury hotels, with 22,395 rooms across 36 hotels in the United States. Park also has interests through joint ventures in another 2,271 rooms in three US hotels. Park was spun out of Hilton Worldwide Holdings at the start of 2017, so most of its hotels are still under Hilton brands. The company has sold all its international hotels and many of its lower-quality US hotels to focus on high-quality assets in domestic gateway markets.

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Share on Social Networks: